Three Classes of Glucocerebrosidase Inhibitors Identified by Quantitative High-Throughput Screening Are Chaperone Leads for Gaucher Disease

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0705637104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase

PLoS ONE
Multidisciplinary
2012English

Correction: Small-Molecule Inhibitors of Acetyltransferase P300 Identified by High-Throughput Screening Are Potent Anticancer Agents

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

High Throughput Screening for Inhibitors of Alpha-Galactosidase

Current Chemical Genomics
2010English

Compound Management for Quantitative High-Throughput Screening

Journal of the Association for Laboratory Automation
2008English

Identification of Three Additional Genes Contiguous to the Glucocerebrosidase Locus on Chromosome 1q21: Implications for Gaucher Disease

Genome Research
Genetics
1997English

Evaluation of Quinazoline Analogues as Glucocerebrosidase Inhibitors With Chaperone Activity

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2011English

Glucocerebrosidase 2 Gene Deletion Rescues Type 1 Gaucher Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

High-Throughput Screening Identified Selective Inhibitors of Exosome Biogenesis and Secretion: A Drug Repurposing Strategy for Advanced Cancer

Scientific Reports
Multidisciplinary
2018English

Identification of Plasmodium Dipeptidyl Aminopeptidase Allosteric Inhibitors by High Throughput Screening

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy